Drug Company Tests Remdesivir’s Inhaled Version as Potential Treatment for COVID-19
Jun 23, 2020 AM EDT
Gilead Sciences, an American biopharmaceutical firm, is soon starting to try remdesivir's inhalable version. Remdesivir is an antiviral medicine that has shown potential as a treatment for COVID-19 in early trials.
